Current Issue·Archives·Upcoming Events·Submit a Story

Additional Articles

UPMC forges partnership to bring world-class health care to Cyprus

A home for biotechnology in Palermo

Researcher's visit to ISMETT

Qatar — Nursing Leadership Course

UPMC business development: Building an integrated global health enterprise

IT at work for a paperless hospital

An interview with a transplant patient at ISMETT

Irish Cancer Centers earn prestigious quality award

Beacon Hospital welcomes new CFO

ISMETT cardiac surgeons act as high school teachers

UPMC at Arab Health 2009

National news coverage of Trilogy Technology at Beacon Hospital

May 2009

A home for biotechnology in Palermo

Work on a new center for biomedical research will start in one year. UPMC to support the entire operation.

Signing of UPMC-Ri.MED agreement
Jeffrey A. Romoff, Paolo Pucci di Benisichi, and Laura  Raimondo pose for a picture after signing the official UPMC-Ri.MED agreement.

UPMC is committed to the worldwide advancement and accessibility of leading-edge medical research and health care. To foster initiatives to improve public health and to develop Sicily as an international point of reference for biotechnologies and biomedicine, UPMC helped establish the Ri.MED (Ricerca Mediterranea) Foundation in 2006 to create a Biomedical Research and Biotechnology Center (BRBC) in Carini, Palermo. Construction is expected to start in 2010.

Ri.MED was developed as a partnership among the Italian government, the Region of Sicily, the National Research Center (CNR), the University of Pittsburgh, and UPMC. The project is based on an initiative of the Council of Ministries, which established the foundation and provided it with a €260 million fund (approximately $340 million). This will be used not only for the construction of the center and starting its activities, but also to train young researchers through the synergy between Italian institutional bodies and U.S. academic centers. 

Thanks to the commitment from UPMC to operate Ri.MED, the project will be the first of its kind. UPMC is not only a founder of Ri.MED, according to an agreement signed in February, it also will be responsible for running the BRBC.

The agreement with UPMC — which is successfully managing ISMETT in Palermo — will enable research to be conducted in Sicily following the same standards applied in the United States.

Ri.MED researchers will be provided with a “home” to enter according to their scientific skills, where they will find the infrastructure and organization necessary to be productive and competitive on an international level. This way Ri.MED can face one of the main limitations in Italy to attracting and retaining young scientists — the lack of infrastructure dedicated to research.

The University of Pittsburgh, the academic partner of UPMC, is strongly committed to research. In the last five years, the University obtained 124 patents, created 41 spin-off companies, and received more than $600 million in grant funding from the National Institutes of Health.

Along with Ri.MED and the CNR, UPMC will work to integrate the BRBC into the national and international academic and industrial research centers. A scientific complex in the center of Carini is expected to be built, in order to generate new products.

Return to list of stories in this issue